2-phenyl-5-formylbenzimidazole | 174648-21-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 英文名称: 2-phenyl-5-formylbenzimidazole
• 英文别名: 2-phenyl-1H-benzimidazole-5-carbaldehyde；2-phenyl-1H-benzoimidazole-5-carbaldehyde；2-phenyl-3H-benzimidazole-5-carbaldehyde
• CAS: 174648-21-6
• 化学式: C₁₄H₁₀N₂O
• 分子量: 222.246
• InChiKey: GBUZAFJDQWEOKA-UHFFFAOYSA-N

物化性质

• 沸点：
  463.9±37.0 °C(Predicted)
• 密度：
  1.291±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  45.8
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-phenyl-5-formylbenzimidazole 在 sodium hydroxide 、 双氧水 、 四丁基硫酸氢铵 作用下， 以 甲醇 、 二氯甲烷 、 硝基苯 为溶剂， 生成 2'-phenyl-5-(aminocarbonyl)-2,5'-bi-1H-benzimidazole
  参考文献：
  名称：

  Substituted 2,5‘-Bi-1H-benzimidazoles:  Topoisomerase I Inhibition and Cytotoxicity

  摘要：

  Several 2'-aryl-5-substituted-2,5'-bi-1H-benzimidazole derivatives were synthesized and evaluated as topoisomerase I poisons and for their cytotoxicity toward the human lymphoblast cell line RPMI 8402. This study focused on 18 2,5'-bi-1H-benzimidazole derivatives which contained either a 5-cyano, a 5-(aminocarbonyl), or a 5-(4-methylpiperazinyl) group. Among these bibenximidazoles, the pharmacological activity of 2'-phenyl derivatives and the influence of the different positional isomers of either a 2'-tolyl group or a 2'-naphthyl moiety on cytotoxicity and topoisomerase I inhibitory activity were determined.

  DOI：

  10.1021/jm950412w
• 作为产物：
  描述：

  3,4-二氨基苯甲腈 在 aluminum nickel 甲酸 作用下， 以 硝基苯 为溶剂， 反应 6.0h， 生成 2-phenyl-5-formylbenzimidazole
  参考文献：
  名称：

  Substituted 2,5‘-Bi-1H-benzimidazoles:  Topoisomerase I Inhibition and Cytotoxicity

  摘要：

  Several 2'-aryl-5-substituted-2,5'-bi-1H-benzimidazole derivatives were synthesized and evaluated as topoisomerase I poisons and for their cytotoxicity toward the human lymphoblast cell line RPMI 8402. This study focused on 18 2,5'-bi-1H-benzimidazole derivatives which contained either a 5-cyano, a 5-(aminocarbonyl), or a 5-(4-methylpiperazinyl) group. Among these bibenximidazoles, the pharmacological activity of 2'-phenyl derivatives and the influence of the different positional isomers of either a 2'-tolyl group or a 2'-naphthyl moiety on cytotoxicity and topoisomerase I inhibitory activity were determined.

  DOI：

  10.1021/jm950412w

文献信息

• [EN] SUBSTITUTED 3-AMINO-THIENO[2,3-B] PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AS IKK INHIBITORS<br/>[FR] COMPOSES AMIDE D'ACIDE 3-AMINO-THIENO[2,3-B] PYRIDINE-2-CARBOXYLIQUE SUBSTITUE SERVANT D'INHIBITEURS D'IKK
  申请人：BOEHRINGER INGELHEIM PHARMA

  公开号：WO2005056562A1

  公开（公告）日：2005-06-23

  Disclosed are compounds of formula (I): wherein the variables R1, R2, R3 and Z are described herein, which are useful as inhibitors of the kinase activity of the IκB kinase (IKK) complex. The compounds are therefore useful in the treatment of IKK mediated diseases including autoimmune diseases inflammatory diseases and cancer. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.

  披露了公式(I)的化合物：其中变量R1、R2、R3和Z如本文所述，它们作为IκB激酶(IKK)复合物的激酶活性的抑制剂是有用的。因此，这些化合物在治疗IKK介导的疾病，包括自身免疫性疾病、炎症性疾病和癌症方面是有用的。还披露了包含这些化合物的药物组合物以及制备这些化合物的方法。
• [EN] NOVEL CHEMICAL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSES CHIMIQUES
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2005082901A1

  公开（公告）日：2005-09-09

  This invention relates to newly identified compounds for inhibiting hYAK3 proteins and methods for treating diseases associated with the imbalance or inappropriate activity of hYAK3 proteins.

  这项发明涉及新识别的化合物，用于抑制hYAK3蛋白，并用于治疗与hYAK3蛋白不平衡或不适当活性相关的疾病的方法。
• Eco-friendly highly efficient solvent free synthesis of benzimidazole derivatives over sulfonic acid functionalized graphene oxide in ambient condition
  作者：Mantosh B. Swami、Arvind H. Jadhav、Sushil R. Mathpati、Hanmant G. Ghuge、Sudhakar G. Patil

  DOI：10.1007/s11164-016-2745-y

  日期：2017.4

  (GO-HSO3) heterogeneous catalyst was prepared at molecular level and characterized by using various modern analytic and spectroscopic methods. Using prepared heterogeneous catalyst GO-HSO3, benzimidazole synthesis was carried out by means of reacting diamine and aldehyde at room temperature in solvent free condition. The catalyst GO-HSO3 showed tremendous catalytic activity in selective synthesis of benzimidazole

  摘要 在分子水平上制备了磺化氧化石墨烯（GO-HSO 3）非均相催化剂，并利用各种现代分析和光谱方法对其进行了表征。使用制备的非均相催化剂GO-HSO 3，通过在室温下在无溶剂条件下使二胺和醛反应来合成苯并咪唑。催化剂GO-HSO 3在选择性合成苯并咪唑中显示出巨大的催化活性，结果使用0.1 mg催化剂在很短的反应时间内即可实现100％的反应物转化率和高达89.0％的相应苯并咪唑产率。GO-HSO 3在反应结束时，通过简单的过滤过程将催化剂从反应混合物中分离出来，并重复使用六个连续的循环，而不会明显降低催化活性和选择性。该方案的关键优势是高产率，低成本，易于后处理，反应时间短和无溶剂条件。发现本方法是在室温下合成苯并咪唑衍生物的环保，高效，无溶剂，高产率和清洁的方法。 图形概要
• Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
  申请人：Chen Zhidong

  公开号：US20050182053A1

  公开（公告）日：2005-08-18

  Disclosed are compounds of formula (I): wherein the variables R 1 , R 2 , R 3 and Z are described herein, which are useful as inhibitors of the kinase activity of the IκB kinase (IKK) complex. The compounds are therefore useful in the treatment of IKK mediated diseases including autoimmune diseases inflammatory diseases and cancer. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.

  本发明公开了式（I）的化合物：其中变量R1，R2，R3和Z如下所述，其可用作IκB激酶（IKK）复合物的激酶活性抑制剂。 因此，这些化合物可用于治疗IKK介导的疾病，包括自身免疫性疾病、炎症性疾病和癌症。 还公开了包含这些化合物的制药组合物和制备这些化合物的过程。
• Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
  申请人：Chen Zhidong

  公开号：US20060270671A1

  公开（公告）日：2006-11-30

  Disclosed are methods of treating cancer by administration of compounds according to formula (I): wherein the variables R 1 , R 2 , R 3 and Z are described herein.

  本发明涉及通过给予式(I)所述化合物治疗癌症的方法：其中变量R1、R2、R3和Z的描述如下。